Summary. Estimation of treatment effects in randomized studies is often hampered by possible selection bias induced by conditioning on or adjusting for a variable measured post-randomization. One approach to obviate such selection bias is to consider inference about treatment effects within principal strata, that is, principal effects. A challenge with this approach is that without strong assumptions principal effects are not identifiable from the observable data. In settings where such assumptions are dubious, identifiable large sample bounds may be the preferred target of inference. In practice these bounds may be wide and not particularly informative. In this work we consider whether bounds on principal effects can be improved by adjusting for a categorical baseline covariate. Adjusted bounds are considered which are shown to never be wider than the unadjusted bounds. Necessary and sufficient conditions are given for which the adjusted bounds will be sharper (i.e., narrower) than the unadjusted bounds. The methods are illustrated using data from a recent, large study of interventions to prevent mother-to-child transmission of HIV through breastfeeding. Using a baseline covariate indicating low birth weight, the estimated adjusted bounds for the principal effect of interest are 63% narrower than the estimated unadjusted bounds.
Introduction
Often in randomized trials to evaluate the effect of a treatment, inference is hampered by possible selection bias induced by conditioning on or adjusting for a variable measured post-randomization. For instance, in randomized clinical trials where some study participants do not comply with their treatment assignment, investigators are often interested in the effect of treatment in participants who were compliant. One approach that avoids potential selection bias induced by conditioning on a post-randomization variable is to focus inference on the causal effect within a principal strata of interest, that is, the principal effect (Frangakis and Rubin, 2002) . Principal strata are defined by the pair of potential outcomes under either treatment assignment of the post-randomization variable. For instance, in the setting of non-compliance the principal stratum of interest may be study participants who would comply with their randomization assignment regardless of whether assigned to treatment or control (Angrist, Imbens, and Rubin, 1996) . In vaccine trials, a principal stratum of interest may be individuals who would be infected at a certain time regardless of vaccine status (Shepherd, Gilbert, and Dupont, 2011) . In studies of interventions to prevent mother-to-child transmission (MTCT) of HIV through breastfeeding, a principal stratum of interest is infants who would be uninfected at a certain time regardless of treatment (Nolen and Hudgens, 2011; Long and Hudgens, 2012) . There are many other settings where inference about treatment effects within certain principal strata may be of interest; see VanderWeele (2011) for a recent overview. A primary goal in these settings is often to better understand a treatment's effect by drawing inference about effects within subgroups defined by the principal strata. The principal stratification approach is less helpful for decision making, as principal stratum membership is generally not identifiable prior to treatment (Joffe, 2011) .
In many instances, even after treatment assignment individual principal strata membership is not identifiable from the observable data without strong assumptions because only one of the two post-randomization variable potential outcomes is ever observed for an individual. In turn, the principal effect of interest is not identifiable. One approach to cope with lack of identifiability is to conduct sensitivity analysis wherein some model is assumed, indexed by an unidentifiable parameter conditional on which the principal effect is identifiable from the observable data. Inference about the principal effect is then conducted conditional on some value of the unidentifiable parameter and sensitivity of the inference is examined by considering different values of the parameter. An alternative approach entails drawing inference about bounds on the principal effects, for example, Zhang and Rubin (2003) and Cheng and Small (2006) . Informally, these extreme bounds provide the smallest and largest possible values of the principal effect consistent with the observed data distribution. This approach is appealing in that typically bounds can be obtained under minimal assumptions. However, in many cases the bounds may be quite wide and therefore not particularly informative about the principal effect. Grilli and Mealli (2008) derived nonparametric bounds on principal effects under a number of different assumptions. They suggested these bounds can be improved (or narrowed) by creating bounds within strata defined by a baseline covariate and combining these stratum specific bounds by taking a weighted average to obtain new adjusted bounds on the principal effect. Grilli and Mealli employed this approach in the analysis of data from an employment study with mixed results: the adjusted bounds were an improvement on only one side of the unadjusted bounds, that is, the adjusted upper bound was less than the unadjusted upper bound but the adjusted lower bound was also less than the unadjusted lower bound. The reason for only partial improvement was not addressed. More recent work by Lee (2009) and Mealli and Pacini (2012) indicate the adjusted bounds will never be wider than the unadjusted bounds and sometimes the adjusted bounds will be strictly narrower than the unadjusted bounds. In this article we characterize the exact circumstances for which adjusting for a baseline covariate leads to improved bounds.
The outline of the remainder of this article is as follows. In Section 2, notation and assumptions are introduced. Section 3 explains the lack of identifiability of the principal effect and in Section 4 the unadjusted bounds are reviewed. Section 5 defines the adjusted bounds based on a weighted average of bounds within levels of the baseline covariate. Section 6 contains the main result of this article, giving necessary and sufficient conditions under which the covariate adjusted bounds improve upon (i.e., are narrower than) the unadjusted bounds. In Section 7 large sample inferential methods are discussed. In Section 8, the adjusted and unadjusted bounds are compared using data from a recent, large MTCT study. Conditions in which adjusting for the covariate leads to identification of the principal effect are discussed in Section 9. A brief discussion is given in Section 10. Proofs of the propositions in Section 6 are given in the Web Appendix A.
Notation and Assumptions
To motivate, throughout we consider the MTCT example where infants of HIV positive mothers are randomized at birth (i.e., baseline or time 0) to treatment or control. Suppose n infants are enrolled in a MTCT study and for i = 1, . . . , n let Z i denote the randomization assignment for infant i. Without loss of generality let Z i = 0 correspond to control and Z i = 1 correspond to treatment. Let X i be some binary variable measured at baseline (prior to randomization) taking on values 0 or 1. For simplicity X i is assumed to be binary for now, although the results derived below will apply for any baseline categorical covariate with a finite number of levels. The primary endpoint in MTCT studies is typically HIV infection of the infant by some time point τ (e.g., 6 months) after baseline. Denote the presence or absence of the primary endpoint by Y i , where Y i = 1 indicates infant i became infected by τ and otherwise Y i = 0. Because the goal of treatment is to prevent breast milk transmission of HIV, investigators are primarily interested in infant HIV infections that occur before τ but after some time τ 0 > 0 (e.g., τ 0 = 2 weeks), as infections prior to τ 0 are likely due to in utero or peripartum transmission and not breastfeeding. Let S i denote whether infant i is infected by τ 0 , where S i = 1 if infant i is HIV infected by τ 0 and S i = 0 otherwise. Let S i (z) denote the potential value of S i when assigned treatment z for z = 0, 1 such that
Define Y i (z) similarly. Assume the treatment assignment of an infant does not affect the potential outcomes of other infants (i.e., there is no interference) and that there are not multiple forms of treatment.
An analysis of the effect of treatment that simply excludes infants infected by τ 0 (i.e., S i = 1) is subject to selection bias.
That is, because the set (or population) of infants that would be infected by τ 0 when assigned treatment Z i = 1 is not necessarily the same as the set of infants that would be infected by τ 0 if assigned control Z i = 0, direct comparisons between trial arms that exclude infants infected by τ 0 in general do not have a causal interpretation. To avoid such selection bias, the principal stratification framework may be adopted (Frangakis and Rubin, 2002) . Principal strata are defined by sets of infants with the same potential outcome pair (S i (0) = s 0 , S i (1) = s 1 ). Define the always infected (AI) principal stratum to be infants with s 0 = s 1 = 1, that is, infants who would be infected at τ 0 regardless of randomization assignment. Similarly define the harmed stratum as those infants with s 0 = 0, s 1 = 1; the protected stratum as those infants with s 0 = 1, s 1 = 0; and the never infected (NI) stratum as those infants with s 0 = s 1 = 0. Based on considerations described above, investigators conducting MTCT trials are interested in the NI stratum. The causal estimand of interest, the principal effect, is the effect of treatment on Y i in infants who would be uninfected at τ 0 under either randomization assignment, namely
Below we consider large sample bounds for CE that do and do not adjust for the baseline covariate X i . Throughout we assume
where ⊥ denotes independence. Assumption 1 will hold in randomized trials. Monotonicity assumes that treatment does no harm with respect to the intermediate variable S i , that is, there are no infants who would be infected by τ 0 only if treated. Under Assumption 2, there are only three possible principal strata: AI, NI, and protected.
Partial Identifiability
In this section we consider identifiability of CE.
Assume γ > 0 as otherwise the NI stratum is empty with probability 1. Under Assumptions 1 and 2,
, which is identifiable from the observed data. However, θ 100 is not identifiable. Following Hudgens and Halloran (2006) note
Under Assumption 1, π 1 is identifiable. Under Assumptions 1 and 2, γ is identifiable because
On the other hand, θ 100 and θ 101 are not identifiable because infants who were assigned treatment and uninfected at τ 0 are a mixture of infants from the protected and NI strata. Solving (1) for θ 100 yields
Equation (2) describes a line with intercept π 1 /γ and slope −(1 − γ)/γ. Any pair of points (θ 101 , θ 100 ) in the unit square that are on this line will give rise to the same observed data distribution. Note that CE is identifiable if and only if γ = 1, (2) is a horizontal line with intercept π 1 and thus
, that is, treatment has no effect on the intermediate variable S i . If π 1 = 1, then (1) implies θ 100 = 1; geometrically this corresponds to the line (2) intersecting the unit square at the upper right corner (1,1). In words, π 1 = 1 means that all treated infants who are uninfected at τ 0 will become infected by τ. Likewise, if π 1 = 0, then (1) implies θ 100 = 0, corresponding to the line (2) intersecting the unit square at the origin (0,0). In words, π 1 = 0 means that all treated infants who are uninfected at τ 0 will not become infected by τ. Otherwise, if γ < 1 and 0 < π 1 < 1, under Assumptions 1 and 2, CE is not identifiable from the observable random variables. On the other hand, θ 000 , π 1 , and γ are identifiable, implying the observed data distribution does reveal some information about possible values for CE, that is, CE is partially identifiable. The focus of the sequel is on large sample bounds, that is, the smallest and largest possible values of CE that are consistent with the observed data law.
Unadjusted Bounds
In this section, we present large sample bounds for CE (Zhang and Rubin, 2003; Hudgens, Hoering, and Self, 2003) that ignore the baseline covariate X. The large sample bounds for CE are found by first bounding θ 100 . The upper bound for θ 100 is obtained by assuming θ 101 = 0 or θ 100 = 1. Likewise, the lower bound for θ 100 is obtained by assuming θ 101 = 1 or θ 100 = 0. These bounds can be envisaged as corresponding to the points where the line (2) intersects the unit square (Hudgens and Halloran, 2006) . In particular, the upper and lower bounds are
Bounds for CE are found by replacing θ 100 by θ u 100 and θ l 100 , that is, CE u = θ u 100 − θ 000 and CE l = θ l 100 − θ 000 . These bounds will be referred to as "unadjusted" bounds because no information from the covariate is used. . These two fictitious trials will be revisited in the next section.
Adjusted Bounds
Next we consider the method proposed by Grilli and Mealli (2008) for adjusting the large sample bounds using the binary baseline covariate X, that is, bounds will be obtained within strata defined by X and then weighted averages of the stratum specific bounds will be computed.
such that the conditional probabilities θ z0tx , γ x , and π zx are all well defined. This assumption also implies γ x > 0, φ x > 0 and λ x > 0 for x = 0, 1. Note
where here and in the sequel
. As in the unadjusted case, θ 100x is not identifiable but using arguments analogous to (2) for
and identifiable upper and lower bounds for θ 100x are
Under Assumptions 1 and 2, φ x is identifiable because
. Therefore, identifiable bounds for θ 100 can be obtained by combining (4) and (6), namely
This leads to adjusted bounds CE A graphical depiction of the unadjusted and adjusted bounds is given in Figure 1 . The unadjusted bounds correspond to where the solid lines intersect the unit square. Bounds within strata defined by X correspond to where the dashed and dotted lines intersect the unit square. The adjusted bounds, represented by • and +, are weighted averages of these stratum specific bounds. For example, in the upper left panel corresponding to trial 1 and X 1 , we see that θ l 100X is greater than θ l 100 because the vertical value of + is greater than zero, the point where the solid line intersects the horizontal axis.
Improvement of the Bounds
The examples in the preceding section illustrate that adjusting for a baseline covariate may or may not improve the bounds on CE. In this section, we give necessary and sufficient conditions for when the adjusted bounds (7) will be narrower than the unadjusted bounds of (3). Proofs of all propositions are given in Web Appendix A.
] for any baseline binary covariate X.
According to Proposition 1, the adjusted bounds will be at least as narrow as the unadjusted bounds no matter the choice of X. This proposition is analogous to Proposition 1b of Lee (2009) for Y continuous. To characterize the conditions under which the adjusted bounds are strictly narrower than the unadjusted bounds, consider the following two criteria:
and
where the value of x in (8) and (9) is not necessarily the same. In words (8) and (9) indicate that X i is informative about particular orderings between (i) the distribution of S i (0) given S i (1) = 0 and (ii) the distribution of Y i (1) given S i (1) = 0. For the motivating example, these criteria indicate that the ordering of (i) the risk of infection (or not) by τ 0 when not treated and (ii) the risk of infection by τ when treated is different between strata defined by the levels of X i among infants who would not be infected by τ 0 if treated. On the other hand, if X i is uninformative about the relation between (i) and (ii) then neither (8) nor (9) will hold. For example, if X i is independent of S i (0) given S i (1) = 0 and if X i is independent of Y i (1) given S i (1) = 0, then neither (8) nor (9) will hold. Using (8) and (9), the following propositions characterize exactly the situations when the adjusted bounds will be narrower.
if and only if X satisfies (8).
Proposition 2 states (8) is a necessary and sufficient condition for the adjusted upper bound for θ 100 to be less than the unadjusted bound. This proposition is exemplified in the second fictional trial from Section 5 using X 1 , where π 10 < γ 0 and π 11 > γ 1 . As shown in the lower left panel of Figure 1 (8) is satisfied because the dashed line has intercept >1 and the dotted line has intercept <1. In contrast, for X 1 in the first fictional trial (8) is not satisfied because the dashed and dotted lines in the upper left panel of Figure 1 both have intercepts <1; thus the adjusted upper bound based on X 1 does not improve upon the unadjusted upper bound. Proposition 3 provides a necessary and sufficient condition for the adjusted lower bound to be greater than the unadjusted lower bound. This proposition is illustrated in the first fictional trial from Section 5 using X 1 , where π 10 > (1 − γ 0 ) and π 11 < (1 − γ 1 ). As shown in the upper left panel of Figure 1 (9) is satisfied because the dashed line intersects the bottom of the unit square whereas the dotted line intersects the right side of the unit square. In contrast, for X 1 in the second ficitious trial (9) is not satisfied because the dashed and dotted lines in the lower left panel of Figure 1 both intersect the right side of the unit square; thus the adjusted lower bound equals the unadjusted lower bound. Additional insight regarding criteria (8) and (9) can be obtained by constructing principal strata based on crossclassification of {S i (0), S i (1)} as well as {Y i (0), Y i (1)}. Further details regarding this approach are given in Web Appendix B.
It follows immediately from Propositions 2 and 3 that if (8) and (9) both hold then the adjusted bounds are strictly contained within the unadjusted bounds and if neither hold, the adjusted and unadjusted bounds are equal. Note while it was assumed that X was a binary covariate, Propositions 1 -3 can immediately be extended to any categorical baseline covariate with a finite number of levels k. Specifically, suppose adjusted bounds are calculated within each of the k strata and weighted averages of these bounds are computed analogous to (7). Then Proposition 1 will hold, and if there exists any two levels of X that satisfy either (8) or (9), then either Proposition 2 or Proposition 3 will hold respectively.
Inference
The unadjusted and adjusted bounds can be consistently estimated by plugging in consistent estimators of the component parameters of the bounds. Specifically, let
and I() is the usual indicator function. Likewise, letφ
In the data example presented in Section 8 below, individuals drop out of the study prior to evaluation of Y i so that the simple moment estimatorsπ z andπ zx given above will not be possible to compute. We ignore this complication for now and will return to this issue below.
Consistent (7). These estimated bounds reflect ignorance due to partial identifiability but do not account for uncertainty due to sampling variability; such uncertainty intervals can be constructed using the approach of Imbens and Manski (2004) and Vansteelandt et al. (2006) . In particular, Lee (2009) (10) where c * α/2 can be computed using equation As n → ∞, the interval (10) will contain CE with probability (1 − α). A pointwise uncertainty interval based on the estimated adjusted bounds can be constructed analogously.
Illustration
The breastfeeding, antiretroviral, and nutrition (BAN) study was a randomized clinical trial to assess interventions for the prevention of breast milk transmission of HIV in 2369 HIV infected mothers and their infants in Lilongwe, Malawi (Chasela et al., 2010) . There were three arms in the BAN study: daily antiretroviral therapy (ART) for the infant, daily ART for the mother, or control. While the primary analysis of the study considered comparisons of both ART arms to control, we will focus on comparing the infant ART and control arms only. The primary endpoint of BAN was infant HIV infection by τ = 28 weeks, so we let Y i = 1 if the infant was HIV positive by 28 weeks and Y i = 0 otherwise. Per protocol, infants who died or were infected in the first 2 weeks post-treatment were to be excluded from the primary analysis. Let S i = 1 if the infant became HIV positive or died by τ 0 = 2 weeks, S i = 0 otherwise. An analysis that compares randomization groups conditional on S i = 0 is subject to selection bias. Instead we let the target of inference be CE, the change in risk of infection by 28 weeks due to infant ART in infants who would be HIV negative and alive at 2 weeks regardless of randomization assignment. Below estimated unadjusted bounds for CE are compared with estimated adjusted bounds based on a
Table 2
Data from the BAN study stratified by X (birth weight < 2.5 kg) 28  10  38  36  3  39  S = 0  584  46  630  751  62  813 binary variable X i indicating low-birth weight (<2.5 kg), that is, X i = 1 if the infant was of low birth weight, 0 otherwise. Table 2 presents data on S and X from BAN by randomization arm. The proportion of infants who die or become HIV infected by 2 weeks is somewhat higher in the control group (5.7% vs. 4.6%), although the difference is not statistically significant (Fisher's exact test two-sided p = 0.35). That the proportion was higher in the control group supports the monotonicity assumption. Because some mother-infant pairs dropped out of the study prior to 28 weeks, the simple moment estimators of π z and π zx given in Section 7 cannot be computed. In the absence of competing risks and informative censoring, π x and π zx can be consistently estimated using the Kalpan-Meier estimator. However, in the BAN study death and breastfeeding cessation prior to HIV infection were competing risks. Therefore the Aalen-Johansen estimator (Aalen and Johansen, 1978) for the cumulative incidence function can be used to estimate π z and π zx ; see Long and Hudgens (2012) for additional details. The Aalen-Johansen estimates (ignoring X) wereπ 0 = 0.0581 andπ 1 = 0.0141. Using these estimates, the estimated unadjusted lower and upper bounds of In this example, the estimated adjusted lower bound is greater than the estimated unadjusted lower bound, which is expected based on Proposition 3 and the fact X i satisfies (9) empirically, that is,π 10 > (1 −γ 0 ) andπ 11 < (1 −γ 1 ). On the other hand, the estimated adjusted upper bound is greater than the estimated unadjusted upper bound, empirically contradicting Proposition 1. That the estimated adjusted upper bound is not less than the estimated unadjusted upper bound is actually not surprising based on Proposition 2 and the fact X i does not satisfy (8) empirically, in particularπ 1x <γ x for x = 0, 1. This suggests the adjusted and unadjusted upper bounds are equal, in which case no particular ordering between the adjusted and unadjusted estimators might be expected. Grilli and Mealli (2008) reported a similar finding in an analysis of employment data of university students. This apparent contradiction between the estimated bounds and Proposition 1 suggests alternative adjusted es- That is, by adjusting for the baseline covariate X indicating lower birth weight, the estimated bounds on CE are 63% narrower than the estimated unadjusted bounds.
Uncertainty intervals corresponding to the estimated unadjusted and adjusted bounds were computed using (10) with bootstrap variance estimates (as in Long and Hudgens 2012) . For the unadjusted bounds, the estimated 95% pointwise uncertainty interval equals [-0.076, -0.025] . Corresponding to the estimated adjusted bounds [ CE l X , CE u X ] based on the low birth weight indicator, the estimated 95% pointwise uncertainty interval equals [−0.069, −0.024] , that is, adjusting for low birth weight also results in a narrower estimated uncertainty interval.
Identifiability
As noted at the end of Section 3, in the absence of covariate X, CE is identifiable if and only if one of the following three conditions occur: γ = 1, π 1 = 1, or π 0 = 0. When at least one of these conditions holds, CE is identifiable and θ u 100 = θ l 100 , that is, the bounds collapse to a single point. In this section we consider conditions under which adjusting for the binary covariate X renders CE identifiable in the sense that the adjusted bounds collapse to a point, that is, CE l X = CE u X . By the form of the adjusted bounds given in (7) and the assumption φ x > 0 for x = 0, 1, it follows that the adjusted bounds yield a single point if and only if
for x = 0 and x = 1. Ding et al. (2011) also considered identifiability of a principal effect when outcomes are truncated by death, which is mathematically identical to the problem considered here. In addition to Assumptions 1 and 2 above, Ding et al. provided two additional assumptions which are sufficient for identifiability:
. Unfortunately, assumption (i), which under Assumption 1 can be equivalently stated as X i ⊥ Y i (z)|{S i (0), S i (1)} for z = 0, 1, is in general not subject to empirical test based on the observable data. Ding et al. also gave sufficient identifiability conditions that do not require (i) but instead require that X takes on at least three levels or is continuous and that the mean of Y satisfies a particular linear model.
In contrast, condition (11) can be assessed from the observable data because γ x and π 1x are identifiable under Assumptions 1 and 2 only. Moreover (11) suggests a strategy for selecting X. In particular, if a covariate X can be found such that (11) holds for x = 0, 1, then CE will be identifiable. If no such covariate is available, then selecting X such that (11) approximately holds for x = 0, 1 should yield adjusted bounds with width close to zero. For instance, in the MTCT from the previous section, the low birth weight indicator covariate X yieldsγ 0 = 1.000, that is (11) empirically holds for x = 0; while (11) does not hold empirically for x = 1,π 11 = 0.0604 is not too far from zero and indeed the birth weight adjusted bounds for CE are substantially narrower than the unadjusted bounds.
Finally, we note two special cases where X i identifies CE. First, suppose X i = 1 if and only if S i (0) = S i (1) = 0, that is, X i is a perfect predictor of membership in the NI principal stratum. Then trivially CE is identifiable under Assumption 1 alone by the stratum of individuals with X i = 1. This first case is related to the "principal score," that is, the probability an individual is within a principal stratum conditional on one or more covariates Jo and Stuart (2009) . In practice, principal scores are not known but predicted based on fitted models using the observed data. For example, in the MTCT setting a model for Pr[S i (0) = S i (1) = 0|X i = x] can be fit using data from infants assigned Z i = 0 because under Assumptions 1 and 2 such infants are in the NI stratum if and only if S i = 0. If a set of one or more baseline covariates (not necessarily binary or even discrete) can be found such that the principal scores for the NI stratum equal zero or one for each individual, then CE is identified by the stratum of individuals with principal scores equal to one. In practice this may not be possible; however, if covariates can be found such that the principal scores for the NI stratum are all close to zero or one, that is, the principal scores are highly predictive of NI stratum membership, then the adjusted bounds constructed by stratifying on a dichotomization of the principal score should have width near zero. For the second special case, suppose Y i = 1 if and only if X i = 1, that is, X i is a perfect predictor of Y i . Then π 10 = 0 and π 11 = 1 implying (11) holds for x = 0 and x = 1 and therefore CE l X = CE u X . In settings where Z i has an effect on Y i and Z i is assigned randomly, no such perfect predictor X i will exist (because X i is measured pre-randomization), such that the second case seems to have little practical implication.
Discussion
In this article we considered whether bounds on principal effects can be improved by adjusting for a categorical baseline covariate. Necessary and sufficient conditions were derived for which the covariate adjusted bounds will be sharper (i.e., narrower) than the unadjusted bounds. The methods were illustrated using data from a study of interventions to prevent mother-to-child transmission of HIV through breastfeeding. Using a baseline covariate indicating low birth weight, the estimated adjusted bounds for the principal effect of interest were 63% narrower than the estimated unadjusted bounds.
The veracity of the analysis of the BAN trial depends on several key assumptions. Assumption 1, independent treatment assignment, is reasonable because infants were randomly assigned treatment. Assumption 2, monotonicity, implies that the treatment is no worse than control for any individual in terms of the intermediate variable S. As mentioned in Section 8 this assumption is supported by the observed data. Additionally, the BAN study principal investigator, Dr. Charles van der Horst, has indicated that monotonicity is reasonable (personal communication). However, in other settings this assumption may be unrealistic. For example, monotonicity might be considered questionable in an analysis comparing the two active arms of the BAN trial, that is, infant ART versus maternal ART. In such settings, bounds that do not require the monotonicity assumption would be needed.
There are several possible avenues of related future research. One possible direction entails studying how adjusting for covariates affects the efficiency with which the bounds are estimated. For example, is it possible that certain covariates could be advantageous to adjust for with respect to sharpening bounds, but disadvantageous to adjust for in terms of efficiency? In the presence of multiple baseline covariates, future research could explore a formal approach for determining which covariates to adjust for (or include in a principal score model) and how to subsequently draw valid inference accounting for the covariate selection process. Related to Assumption 2, future research could examine relations between adjusted and unadjusted bounds when monotonicity is assumed for the primary endpoint Y .
Supplementary Materials
Web Appendices referenced in Sections 1 and 6 are available with this paper at the Biometrics website on Wiley Online Library.
Copyright of Biometrics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
